| Literature DB >> 365797 |
E Camarri, R Marcolongo, F Fici.
Abstract
Administration of chenodeoxycholic acid (CDCA), 200 mg/day, for 5 days to patients with primary hypertriglyceridemia reduced by 34% the serum triglycerides concentration. Reduction after CDCA is statistically significant vs. the placebo. Even after a short time of CDCA administration, the pharmacological effect is clearly evident.Entities:
Mesh：
Substances：
Year: 1978 PMID： 365797
Source DB: PubMed Journal: Int J Clin Pharmacol Biopharm ISSN： 0340-0026